Flow diversion aneurysm Market

Upcoming

2023

by Product (Intrasaccular flow disruption devices, FDS): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare	Report Code: A03774	Nov 2023 \| Pages: NA
Tables: NA	Charts: NA	Formats*: Single User License, Five User License & Enterprise User License Data Pack Excel License It comes with the additional cost of $2500.00 contact sales.

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Flow Diversion Aneurysm Market

Request Now !

Flow diversion is a novel therapeutic approach for the treatment of anatomically challenging intracranial aneurysms, and this approach has gained traction over the years. Flow diversion aneurysm is an endovascular technique in which the device is placed in the parent blood vessel to divert blood flow away from the aneurysm itself. The technological advancements along with the clinical results indicate that flow diversion aneurysm is safe as well as effective in the treatment of ruptured aneurysms, posterior circulation aneurysms, and distal anterior circulation aneurysms.

Increase in incidence of brain aneurysm and rise in demand for minimally invasive endovascular surgeries drive the market. However, risk of post-operative complications and stringent regulations regarding the approval of the devices restrain the market growth. Moreover, technological advancements in the flow diversion aneurysm treatment offer lucrative opportunities for the expansion of the market.

The market is segmented on the basis of region. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key players that operate in the market are Balt Extrusion, Medtronic Plc, Stryker Corporation, Acandis GmbH, InspireMD, phenox GmbH, and MicroVention, Inc.

Key Benefits

The study provides an in-depth analysis of the global flow diversion aneurysm market with current trends and future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
Key players are profiled and their strategies thoroughly analyzed, which predicts the competitive outlook of the market.

Flow Diversion Aneurysm Market Report Highlights

Aspects	Details
By Product	Intrasaccular flow disruption devices FDS
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Medtronic Plc, Boston Scientific Corp., MicroVention, Inc., Stryker Corporation, Cardinal Health Inc., Cook Group Inc., Phenox GmbH, Balt Extrusion, Acandis GmbH, InspireMD

CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
  - 1.4.1. Primary Research
  - 1.4.2. Secondary Research
  - 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
  - 3.2.1. Top Investment Pockets
  - 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
  - 3.3.1. Bargaining Power of Suppliers
  - 3.3.2. Threat of New Entrants
  - 3.3.3. Threat of Substitutes
  - 3.3.4. Competitive Rivalry
  - 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
  - 3.5.1. Drivers
  - 3.5.2. Restraints
  - 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
CHAPTER 4: FLOW DIVERSION ANEURYSM MARKET, BY PRODUCT
- 4.1. Market Overview
  - 4.1.1 Market Size and Forecast, By Product
- 4.2. Intrasaccular Flow Disruption Devices
  - 4.2.1. Key Market Trends, Growth Factors and Opportunities
  - 4.2.2. Market Size and Forecast, By Region
  - 4.2.3. Market Share Analysis, By Country
- 4.3. FDS
  - 4.3.1. Key Market Trends, Growth Factors and Opportunities
  - 4.3.2. Market Size and Forecast, By Region
  - 4.3.3. Market Share Analysis, By Country
CHAPTER 5: FLOW DIVERSION ANEURYSM MARKET, BY REGION
- 5.1. Market Overview
  - 5.1.1 Market Size and Forecast, By Region
- 5.2. North America
  - 5.2.1. Key Market Trends and Opportunities
  - 5.2.2. Market Size and Forecast, By Product
  - 5.2.3. Market Size and Forecast, By Country
  - 5.2.4. U.S. Flow Diversion Aneurysm Market
    - 5.2.4.1. Market Size and Forecast, By Product
  - 5.2.5. Canada Flow Diversion Aneurysm Market
    - 5.2.5.1. Market Size and Forecast, By Product
  - 5.2.6. Mexico Flow Diversion Aneurysm Market
    - 5.2.6.1. Market Size and Forecast, By Product
- 5.3. Europe
  - 5.3.1. Key Market Trends and Opportunities
  - 5.3.2. Market Size and Forecast, By Product
  - 5.3.3. Market Size and Forecast, By Country
  - 5.3.4. France Flow Diversion Aneurysm Market
    - 5.3.4.1. Market Size and Forecast, By Product
  - 5.3.5. Germany Flow Diversion Aneurysm Market
    - 5.3.5.1. Market Size and Forecast, By Product
  - 5.3.6. Italy Flow Diversion Aneurysm Market
    - 5.3.6.1. Market Size and Forecast, By Product
  - 5.3.7. Spain Flow Diversion Aneurysm Market
    - 5.3.7.1. Market Size and Forecast, By Product
  - 5.3.8. UK Flow Diversion Aneurysm Market
    - 5.3.8.1. Market Size and Forecast, By Product
  - 5.3.9. Russia Flow Diversion Aneurysm Market
    - 5.3.9.1. Market Size and Forecast, By Product
  - 5.3.10. Rest Of Europe Flow Diversion Aneurysm Market
    - 5.3.10.1. Market Size and Forecast, By Product
- 5.4. Asia-Pacific
  - 5.4.1. Key Market Trends and Opportunities
  - 5.4.2. Market Size and Forecast, By Product
  - 5.4.3. Market Size and Forecast, By Country
  - 5.4.4. China Flow Diversion Aneurysm Market
    - 5.4.4.1. Market Size and Forecast, By Product
  - 5.4.5. Japan Flow Diversion Aneurysm Market
    - 5.4.5.1. Market Size and Forecast, By Product
  - 5.4.6. India Flow Diversion Aneurysm Market
    - 5.4.6.1. Market Size and Forecast, By Product
  - 5.4.7. South Korea Flow Diversion Aneurysm Market
    - 5.4.7.1. Market Size and Forecast, By Product
  - 5.4.8. Australia Flow Diversion Aneurysm Market
    - 5.4.8.1. Market Size and Forecast, By Product
  - 5.4.9. Thailand Flow Diversion Aneurysm Market
    - 5.4.9.1. Market Size and Forecast, By Product
  - 5.4.10. Malaysia Flow Diversion Aneurysm Market
    - 5.4.10.1. Market Size and Forecast, By Product
  - 5.4.11. Indonesia Flow Diversion Aneurysm Market
    - 5.4.11.1. Market Size and Forecast, By Product
  - 5.4.12. Rest of Asia Pacific Flow Diversion Aneurysm Market
    - 5.4.12.1. Market Size and Forecast, By Product
- 5.5. LAMEA
  - 5.5.1. Key Market Trends and Opportunities
  - 5.5.2. Market Size and Forecast, By Product
  - 5.5.3. Market Size and Forecast, By Country
  - 5.5.4. Brazil Flow Diversion Aneurysm Market
    - 5.5.4.1. Market Size and Forecast, By Product
  - 5.5.5. South Africa Flow Diversion Aneurysm Market
    - 5.5.5.1. Market Size and Forecast, By Product
  - 5.5.6. Saudi Arabia Flow Diversion Aneurysm Market
    - 5.5.6.1. Market Size and Forecast, By Product
  - 5.5.7. UAE Flow Diversion Aneurysm Market
    - 5.5.7.1. Market Size and Forecast, By Product
  - 5.5.8. Argentina Flow Diversion Aneurysm Market
    - 5.5.8.1. Market Size and Forecast, By Product
  - 5.5.9. Rest of LAMEA Flow Diversion Aneurysm Market
    - 5.5.9.1. Market Size and Forecast, By Product
CHAPTER 6: COMPETITIVE LANDSCAPE
- 6.1. Introduction
- 6.2. Top Winning Strategies
- 6.3. Product Mapping Of Top 10 Player
- 6.4. Competitive Dashboard
- 6.5. Competitive Heatmap
- 6.6. Top Player Positioning,2022
CHAPTER 7: COMPANY PROFILES
- 7.1. Balt Extrusion
  - 7.1.1. Company Overview
  - 7.1.2. Key Executives
  - 7.1.3. Company Snapshot
  - 7.1.4. Operating Business Segments
  - 7.1.5. Product Portfolio
  - 7.1.6. Business Performance
  - 7.1.7. Key Strategic Moves and Developments
- 7.2. Medtronic Plc
  - 7.2.1. Company Overview
  - 7.2.2. Key Executives
  - 7.2.3. Company Snapshot
  - 7.2.4. Operating Business Segments
  - 7.2.5. Product Portfolio
  - 7.2.6. Business Performance
  - 7.2.7. Key Strategic Moves and Developments
- 7.3. Stryker Corporation
  - 7.3.1. Company Overview
  - 7.3.2. Key Executives
  - 7.3.3. Company Snapshot
  - 7.3.4. Operating Business Segments
  - 7.3.5. Product Portfolio
  - 7.3.6. Business Performance
  - 7.3.7. Key Strategic Moves and Developments
- 7.4. Acandis GmbH
  - 7.4.1. Company Overview
  - 7.4.2. Key Executives
  - 7.4.3. Company Snapshot
  - 7.4.4. Operating Business Segments
  - 7.4.5. Product Portfolio
  - 7.4.6. Business Performance
  - 7.4.7. Key Strategic Moves and Developments
- 7.5. InspireMD
  - 7.5.1. Company Overview
  - 7.5.2. Key Executives
  - 7.5.3. Company Snapshot
  - 7.5.4. Operating Business Segments
  - 7.5.5. Product Portfolio
  - 7.5.6. Business Performance
  - 7.5.7. Key Strategic Moves and Developments
- 7.6. Phenox GmbH
  - 7.6.1. Company Overview
  - 7.6.2. Key Executives
  - 7.6.3. Company Snapshot
  - 7.6.4. Operating Business Segments
  - 7.6.5. Product Portfolio
  - 7.6.6. Business Performance
  - 7.6.7. Key Strategic Moves and Developments
- 7.7. MicroVention, Inc.
  - 7.7.1. Company Overview
  - 7.7.2. Key Executives
  - 7.7.3. Company Snapshot
  - 7.7.4. Operating Business Segments
  - 7.7.5. Product Portfolio
  - 7.7.6. Business Performance
  - 7.7.7. Key Strategic Moves and Developments
- 7.8. Boston Scientific Corp.
  - 7.8.1. Company Overview
  - 7.8.2. Key Executives
  - 7.8.3. Company Snapshot
  - 7.8.4. Operating Business Segments
  - 7.8.5. Product Portfolio
  - 7.8.6. Business Performance
  - 7.8.7. Key Strategic Moves and Developments
- 7.9. Cardinal Health Inc.
  - 7.9.1. Company Overview
  - 7.9.2. Key Executives
  - 7.9.3. Company Snapshot
  - 7.9.4. Operating Business Segments
  - 7.9.5. Product Portfolio
  - 7.9.6. Business Performance
  - 7.9.7. Key Strategic Moves and Developments
- 7.10. Cook Group Inc.
  - 7.10.1. Company Overview
  - 7.10.2. Key Executives
  - 7.10.3. Company Snapshot
  - 7.10.4. Operating Business Segments
  - 7.10.5. Product Portfolio
  - 7.10.6. Business Performance
  - 7.10.7. Key Strategic Moves and Developments

LIST OF TABLES
TABLE 1. GLOBAL FLOW DIVERSION ANEURYSM MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 2. GLOBAL FLOW DIVERSION ANEURYSM MARKET FOR INTRASACCULAR FLOW DISRUPTION DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 3. GLOBAL FLOW DIVERSION ANEURYSM MARKET FOR FDS, BY REGION, 2022-2032 ($MILLION)
TABLE 4. GLOBAL FLOW DIVERSION ANEURYSM MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 5. NORTH AMERICA FLOW DIVERSION ANEURYSM, BY REGION, 2022-2032 ($MILLION)
TABLE 6. NORTH AMERICA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 7. U.S. FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 8. CANADA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 9. MEXICO FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 10. EUROPE FLOW DIVERSION ANEURYSM, BY REGION, 2022-2032 ($MILLION)
TABLE 11. EUROPE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 12. FRANCE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 13. GERMANY FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 14. ITALY FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 15. SPAIN FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 16. UK FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 17. RUSSIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 18. REST OF EUROPE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 19. ASIA-PACIFIC FLOW DIVERSION ANEURYSM, BY REGION, 2022-2032 ($MILLION)
TABLE 20. ASIA-PACIFIC FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. CHINA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. JAPAN FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 23. INDIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. SOUTH KOREA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. AUSTRALIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 26. THAILAND FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. MALAYSIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. INDONESIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 29. REST OF ASIA PACIFIC FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 30. LAMEA FLOW DIVERSION ANEURYSM, BY REGION, 2022-2032 ($MILLION)
TABLE 31. LAMEA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 32. BRAZIL FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 33. SOUTH AFRICA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. SAUDI ARABIA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. UAE FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 36. ARGENTINA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. REST OF LAMEA FLOW DIVERSION ANEURYSM, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. BALT EXTRUSION: KEY EXECUTIVES
TABLE 39. BALT EXTRUSION: COMPANY SNAPSHOT
TABLE 40. BALT EXTRUSION: OPERATING SEGMENTS
TABLE 41. BALT EXTRUSION: PRODUCT PORTFOLIO
TABLE 42. BALT EXTRUSION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 43. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 44. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 45. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 46. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 47. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 48. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 49. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 50. STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 51. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 52. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 53. ACANDIS GMBH: KEY EXECUTIVES
TABLE 54. ACANDIS GMBH: COMPANY SNAPSHOT
TABLE 55. ACANDIS GMBH: OPERATING SEGMENTS
TABLE 56. ACANDIS GMBH: PRODUCT PORTFOLIO
TABLE 57. ACANDIS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58. INSPIREMD: KEY EXECUTIVES
TABLE 59. INSPIREMD: COMPANY SNAPSHOT
TABLE 60. INSPIREMD: OPERATING SEGMENTS
TABLE 61. INSPIREMD: PRODUCT PORTFOLIO
TABLE 62. INSPIREMD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63. PHENOX GMBH: KEY EXECUTIVES
TABLE 64. PHENOX GMBH: COMPANY SNAPSHOT
TABLE 65. PHENOX GMBH: OPERATING SEGMENTS
TABLE 66. PHENOX GMBH: PRODUCT PORTFOLIO
TABLE 67. PHENOX GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68. MICROVENTION, INC.: KEY EXECUTIVES
TABLE 69. MICROVENTION, INC.: COMPANY SNAPSHOT
TABLE 70. MICROVENTION, INC.: OPERATING SEGMENTS
TABLE 71. MICROVENTION, INC.: PRODUCT PORTFOLIO
TABLE 72. MICROVENTION, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73. BOSTON SCIENTIFIC CORP.: KEY EXECUTIVES
TABLE 74. BOSTON SCIENTIFIC CORP.: COMPANY SNAPSHOT
TABLE 75. BOSTON SCIENTIFIC CORP.: OPERATING SEGMENTS
TABLE 76. BOSTON SCIENTIFIC CORP.: PRODUCT PORTFOLIO
TABLE 77. BOSTON SCIENTIFIC CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78. CARDINAL HEALTH INC.: KEY EXECUTIVES
TABLE 79. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 80. CARDINAL HEALTH INC.: OPERATING SEGMENTS
TABLE 81. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
TABLE 82. CARDINAL HEALTH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83. COOK GROUP INC.: KEY EXECUTIVES
TABLE 84. COOK GROUP INC.: COMPANY SNAPSHOT
TABLE 85. COOK GROUP INC.: OPERATING SEGMENTS
TABLE 86. COOK GROUP INC.: PRODUCT PORTFOLIO
TABLE 87. COOK GROUP INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL FLOW DIVERSION ANEURYSM MARKET SEGMENTATION
FIGURE 2. GLOBAL FLOW DIVERSION ANEURYSM MARKET
FIGURE 3. SEGMENTATION FLOW DIVERSION ANEURYSM MARKET
FIGURE 4. TOP INVESTMENT POCKET IN FLOW DIVERSION ANEURYSM MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALFLOW DIVERSION ANEURYSM MARKET
FIGURE 11. FLOW DIVERSION ANEURYSM MARKET SEGMENTATION, BY BY PRODUCT
FIGURE 12. FLOW DIVERSION ANEURYSM MARKET FOR INTRASACCULAR FLOW DISRUPTION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 13. FLOW DIVERSION ANEURYSM MARKET FOR FDS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: FLOW DIVERSION ANEURYSM MARKET
FIGURE 20. Top player positioning, 2022
FIGURE 21. BALT EXTRUSION: NET SALES, 2020-2022 ($MILLION)
FIGURE 22. BALT EXTRUSION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 23. BALT EXTRUSION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 24. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 25. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 26. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 27. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 28. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 29. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 30. ACANDIS GMBH: NET SALES, 2020-2022 ($MILLION)
FIGURE 31. ACANDIS GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 32. ACANDIS GMBH: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 33. INSPIREMD: NET SALES, 2020-2022 ($MILLION)
FIGURE 34. INSPIREMD: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 35. INSPIREMD: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 36. PHENOX GMBH: NET SALES, 2020-2022 ($MILLION)
FIGURE 37. PHENOX GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 38. PHENOX GMBH: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 39. MICROVENTION, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 40. MICROVENTION, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 41. MICROVENTION, INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 42. BOSTON SCIENTIFIC CORP.: NET SALES, 2020-2022 ($MILLION)
FIGURE 43. BOSTON SCIENTIFIC CORP.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 44. BOSTON SCIENTIFIC CORP.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 45. CARDINAL HEALTH INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 46. CARDINAL HEALTH INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 47. CARDINAL HEALTH INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 48. COOK GROUP INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 49. COOK GROUP INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 50. COOK GROUP INC.: REVENUE SHARE, BY REGION, 2032 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

U.S.-Canada Toll-free: +1-800-792-5285
Int'l :	+1-503-894-6022
Europe :	+44-845-528-1300
Email :	help@alliedmarketresearch.com

Life Sciences	Construction & Manufacturing	Semiconductor & Electronics
Consumer Goods	Food & Beverages	Automotive & Tarnsportation
Materials & Chemicals	Energy & Power	ICT & Media
Aerospace & Defense	BFSI
You must check at least one industry.

Your Shopping Cart Is Empty

Continue Shopping

Flow Diversion Aneurysm Market Global Opportunity Analysis and Industry Forecast, 2023-2032

2023

Flow Diversion Aneurysm Market

Flow Diversion Aneurysm Market

by Product (Intrasaccular flow disruption devices, FDS): Global Opportunity Analysis and Industry Forecast, 2023-2032

COVID-19

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Market Segments

1.3. Key Benefits

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. Porter's Five Forces Analysis

3.3.1. Bargaining Power of Suppliers

3.3.2. Threat of New Entrants

3.3.3. Threat of Substitutes

3.3.4. Competitive Rivalry

3.3.5. Bargaining Power among Buyers

3.5. Market Dynamics

3.5.1. Drivers

3.5.2. Restraints

3.5.3. Opportunities

3.6. COVID-19 Impact Analysis

CHAPTER 4: FLOW DIVERSION ANEURYSM MARKET, BY PRODUCT

4.1. Market Overview

4.1.1 Market Size and Forecast, By Product

4.2. Intrasaccular Flow Disruption Devices

4.2.1. Key Market Trends, Growth Factors and Opportunities

4.2.2. Market Size and Forecast, By Region

4.2.3. Market Share Analysis, By Country

4.3. FDS

4.3.1. Key Market Trends, Growth Factors and Opportunities

4.3.2. Market Size and Forecast, By Region

4.3.3. Market Share Analysis, By Country

CHAPTER 5: FLOW DIVERSION ANEURYSM MARKET, BY REGION

5.1. Market Overview

5.1.1 Market Size and Forecast, By Region

5.2. North America

5.2.1. Key Market Trends and Opportunities

5.2.2. Market Size and Forecast, By Product

5.2.3. Market Size and Forecast, By Country

5.2.4. U.S. Flow Diversion Aneurysm Market

5.2.4.1. Market Size and Forecast, By Product

5.2.5. Canada Flow Diversion Aneurysm Market

5.2.5.1. Market Size and Forecast, By Product

5.2.6. Mexico Flow Diversion Aneurysm Market

5.2.6.1. Market Size and Forecast, By Product

5.3. Europe

5.3.1. Key Market Trends and Opportunities

5.3.2. Market Size and Forecast, By Product

5.3.3. Market Size and Forecast, By Country

5.3.4. France Flow Diversion Aneurysm Market

5.3.4.1. Market Size and Forecast, By Product

5.3.5. Germany Flow Diversion Aneurysm Market

5.3.5.1. Market Size and Forecast, By Product

5.3.6. Italy Flow Diversion Aneurysm Market

5.3.6.1. Market Size and Forecast, By Product

5.3.7. Spain Flow Diversion Aneurysm Market

5.3.7.1. Market Size and Forecast, By Product

5.3.8. UK Flow Diversion Aneurysm Market

5.3.8.1. Market Size and Forecast, By Product

5.3.9. Russia Flow Diversion Aneurysm Market

5.3.9.1. Market Size and Forecast, By Product

5.3.10. Rest Of Europe Flow Diversion Aneurysm Market

5.3.10.1. Market Size and Forecast, By Product

5.4. Asia-Pacific

5.4.1. Key Market Trends and Opportunities

5.4.2. Market Size and Forecast, By Product

5.4.3. Market Size and Forecast, By Country

Flow Diversion Aneurysm Market
Global Opportunity Analysis and Industry Forecast, 2023-2032